Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris
The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive to the disinfectant chlorhexidine in vitro.
Main Authors: | Leighann Sherry, Gordon Ramage, Ryan Kean, Andrew Borman, Elizabeth M. Johnson, Malcolm D. Richardson, Riina Rautemaa-Richardson |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2017-02-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/23/2/16-1320_article |
Similar Items
-
Indifferent effect of nonsteroidal anti-inflammatory drugs (NSAIDs) combined with fluconazole against multidrug-resistant Candida auris
by: Fatemeh Ahangarkani, et al.
Published: (2019-09-01) -
Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance
by: Ryan Kean, et al.
Published: (2018-07-01) -
Candida auris: From Multidrug Resistance to Pan-Resistant Strains
by: Ademe M, et al.
Published: (2020-05-01) -
Candida auris: An emerging multidrug-resistant pathogen
by: David Sears, et al.
Published: (2017-10-01) -
Antifungal Resistance: Specific Focus on Multidrug Resistance in <i>Candida auris</i> and Secondary Azole Resistance in <i>Aspergillus fumigatus</i>
by: Sevtap Arikan-Akdagli, et al.
Published: (2018-12-01)